Skip to main content

To Perform or Not to Perform Radioiodine Scans Prior to 131I Remnant Ablation? PRO

  • Chapter
  • First Online:
Thyroid Cancer

Abstract

The utility of radioiodine pre-remnant ablation scans remains very controversial. This chapter argues for performing radioiodine pre-remnant ablation scans. There are five main arguments that are typically presented against the utility of pre-remnant ablation scans: (1) “no useful data is obtained from pre-remnant ablation radioiodine scans that will alter my management,” (2) “everything I need to know is on the post-therapy scan,” (3) stunning, (4) the potential benefit is not worth the costs or inconveniences, and (5) until data are published demonstrating that the pre-131I therapy scans alter patient outcomes, these scans should not be performed. This chapter presents a point by counterpoint discussion of the arguments for and against pre-therapy radioiodine ablation. The chapter concludes with rarely discussed issues that in my opinion may be important points regarding the differences in opinions of the utility of pre-remnant ablation radioiodine scans.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y, Pacini F, Randolph G, Sawka A, Schlumberger M, Schuff K, Sherman S, Sosa J, Steward D, Tuttle, R, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.

    Google Scholar 

  2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803.

    Article  CAS  PubMed  Google Scholar 

  3. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Thyroid carcinoma. Follicular thyroid carcinoma. V.2.2013.

    Google Scholar 

  4. British Thyroid Association and Royal College of Physicians. Guidelines/statements the British Thyroid Association 2014 edition of the Thyroid Cancer Guidelines (Draft). Available at: http://www.british-thyroid-association.org/Guidelines/.

  5. Silberstein EB, Alvai A, Balon H, et al. The SNM pracice guideline for therapy of thyroid disease with 131I, 3.0. J Nucl Med. 2012;53:1633–51.

    Article  PubMed  Google Scholar 

  6. Van Nostrand D, Aiken M, Atkins F, Moreau S, Garcia C, Acio E, Burman K, Wartofsky L. The utility of radioiodine scans prior to 131I ablation in patients with well-differentiated thyroid cancer. Thyroid. 2009;19:849–55.

    Article  PubMed  Google Scholar 

  7. Chen MK, Yasrebi M, Samii J, Staib LH, Doddamane I, Cheng DW. The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer. Thyroid. 2012;22:304–9.

    Article  CAS  PubMed  Google Scholar 

  8. McDougall IR. Differentiated thyroid cancer. In: McDougall IR, editor. Management of thyroid cancer and related nodular disease. London: Springer; 2006. p. 173.

    Google Scholar 

  9. Amdur RJ, Mazzaferri EL. The role of a diagnostic radioiodine whole body scan (DxSCAN). In: Amdur RJ, Mazzaferri E, editors. Essentials of thyroid cancer management. Springer: New York; 2005. p. 63.

    Chapter  Google Scholar 

  10. Haq MS, Harmer C. Non-surgical management of thyroid cancer. In: Mazzaferri E, Harmer C, Mallick UK, Kendall-Taylor P, editors. Practical management of thyroid cancer. London: Springer; 2006. p. 174.

    Google Scholar 

  11. Schlumberger MJ, Leboulleux SM, Pacini F. Follow-up of patients with differentiated thyroid carcinoma. In: Mazzaferri EL, Harmer C, Mallick UJ, Kendall-Taylor P, editors. Practical management of thyroid cancer. New York: Springer; 1996. p. 231.

    Google Scholar 

  12. Schlumberger MJ, Pacini F. The low utility of pretherapy scans in thyroid cancer patients. Thyroid. 2009;19:815–6.

    Article  PubMed  Google Scholar 

  13. McDougall IR. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer. Thyroid. 2009;19:811–3.

    Article  PubMed  Google Scholar 

  14. Spanu A, Solinas ME, Chessa F, Sanna D, Nuvoli S, Madeddu S. 131I SPECT-CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med. 2009;50:184–90.

    Article  PubMed  Google Scholar 

  15. Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, Sandler MP, Delbeke D. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:1435–42.

    Article  CAS  PubMed  Google Scholar 

  16. Hilditch TE, Dempsey MF, Bolster AA, McMenemin RM, Reed NS. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I. Eur J Nucl Med Mol Imaging. 2002;29:783–8.

    Article  CAS  PubMed  Google Scholar 

  17. Gerard SK, Park HM. Stunning and I-123 use for diagnostic whole body scanning: letter to the editor. Thyroid. 2006;16:817.

    Article  PubMed  Google Scholar 

  18. MIRD (Medical Internal Radiation Dose) Committee 1975 Report #5. Summary of current radiation dose estimates to humans from 123I, 124I, 125I, 126I, 130I, 131I, and 132I as sodium iodide. J Nucl Med. 1975; 16:857–60.

    Google Scholar 

  19. Lundh C, Lindencrona U, Postgard P, Carlsson T, Nilsson M, Forssell-Aronsson E. Radiation-induced thyroid stunning: differential effects of 123I, 131 I, 99mTc, and 211AT on iodide transport and NIS mRNA expression in cultured thyroid cells. J Nucl Med. 2009;50:116–1171.

    Article  Google Scholar 

  20. McDougall IR, Iagaru A. Thyroid stunning: fact or fiction. Sem Nucl Med. 2011;41:105–12.

    Article  Google Scholar 

  21. Bahk YW, editor. Combined scintigraphic and radiographic diagnosis of bone and joint diseases. 2nd ed. Berlin: Springer; 2000.

    Google Scholar 

  22. Kulkarni K, Van Nostrand D, Young-Rok S, Aiken M, Mete M, Burman K, Wartofsky L. Detectability of foci of radioiodine uptake in the thyroid bed and neck comparing pinhole with parallel-hole collimators. Nuc Med Comm. 2011;32:369–74.

    Article  Google Scholar 

  23. Chennupati S, Van Nostrand D, Kharazi P, Khorjekar G. Determination of the number of foci of normal thyroid tissue remaining after thyroidectomy in patients with differentiated thyroid cancer: the Washington hospital center experience. J Nucl Med. 2011;52S:1300.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Douglas Van Nostrand MD, FACP, FACNM .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Van Nostrand, D. (2016). To Perform or Not to Perform Radioiodine Scans Prior to 131I Remnant Ablation? PRO. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics